Effect of intravenous adenosine on human atrial and ventricular repolarisation. 1992

S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
Department of Cardiological Sciences, St George's Hospital Medical School, London, United Kingdom.

OBJECTIVE The aim was to assess the effects of therapeutic doses of intravenous adenosine on human atrial and ventricular repolarisation. METHODS The effects of 6 mg and 12 mg bolus doses of adenosine on the atrial and ventricular monophasic action potentials were studied using the contact catheter technique in 19 patients undergoing routine diagnostic electrophysiology studies. The effect on atrial repolarisation was studied before and after beta blockade in a subgroup of patients. RESULTS The duration of the monophasic action potential to 90% repolarisation (MAPD90) was measured in all cases. After 6 mg of adenosine the atrial MAPD90 shortened from 227(SD 29) ms to 188(25) ms (p < 0.005); after 12 mg it shortened from 221(31) ms to 168(32) ms (p < 0.001). The maximum shortening was unaltered by propranolol 0.15 mg.kg-1. The ventricular MAPD90 showed no significant change after 12 mg, at 240(32) ms v 234(33) ms. CONCLUSIONS Therapeutic doses of adenosine shorten the atrial but not the ventricular monophasic action potential duration. The effect is dose dependent and not abolished by beta blockade.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan

Related Publications

S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
July 1977, British heart journal,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
March 1993, British heart journal,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
June 2000, Japanese circulation journal,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
February 1986, British heart journal,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
December 1995, Archives des maladies du coeur et des vaisseaux,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
July 2002, Cardiovascular drugs and therapy,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
January 2005, Nephron. Clinical practice,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
December 1986, Canadian journal of physiology and pharmacology,
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
March 2000, Heart (British Cardiac Society),
S O Nunain, and C Garratt, and V Paul, and N Debbas, and D E Ward, and A J Camm
December 2005, Archives des maladies du coeur et des vaisseaux,
Copied contents to your clipboard!